Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein - PubMed (original) (raw)
. 1996 Oct 11;271(41):25492-7.
doi: 10.1074/jbc.271.41.25492.
Affiliations
- PMID: 8810320
- DOI: 10.1074/jbc.271.41.25492
Free article
Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein
A P Levy et al. J Biol Chem. 1996.
Free article
Abstract
Hypoxia induces an increase in the stability of the mRNA encoding vascular endothelial growth factor (VEGF). We have previously demonstrated that a 500-base region of the 3'-untranslated region of VEGF mRNA that is critical for stabilization of VEGF mRNA in an in vitro degradation assay forms a RNA-protein complex in a hypoxia-inducible fashion. We report here the identification of three adenylate-uridylate-rich RNA elements within this region that form an identical or closely related hypoxia-inducible RNA-protein complex. This complex is constitutively elevated in a tumor cell line lacking the wild type von Hippel-Lindau tumor suppressor gene and in which VEGF mRNA is constitutively stabilized. Furthermore, the glucose transporter-1 mRNA, which is also stabilized by hypoxia, forms a hypoxia-inducible RNA-protein complex with similar sequence and protein binding characteristics to that described for VEGF mRNA. Finally, RNA affinity purification and UV cross-linking were used to identify three proteins of 32, 28, and 17 kDa that are derived from this hypoxia-inducible RNA-protein complex.
Similar articles
- Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS, Münchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jürgensen JS, Gruber G, Maxwell PH, Löning SA, Frei U, Maher ER, Gröne HJ, Eckardt KU. Wiesener MS, et al. Cancer Res. 2001 Jul 1;61(13):5215-22. Cancer Res. 2001. PMID: 11431362 - Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene.
Levy AP, Levy NS, Iliopoulos O, Jiang C, Kaplin WG Jr, Goldberg MA. Levy AP, et al. Kidney Int. 1997 Feb;51(2):575-8. doi: 10.1038/ki.1997.82. Kidney Int. 1997. PMID: 9027742 Review. - The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein.
Conaway JW, Kamura T, Conaway RC. Conaway JW, et al. Biochim Biophys Acta. 1998 Apr 17;1377(2):M49-54. doi: 10.1016/s0304-419x(97)00035-8. Biochim Biophys Acta. 1998. PMID: 9606976 Review. No abstract available.
Cited by
- Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, Pause A. Iwai K, et al. Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12436-41. doi: 10.1073/pnas.96.22.12436. Proc Natl Acad Sci U S A. 1999. PMID: 10535940 Free PMC article. - Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function.
Sinha S, Mondal G, Hwang EJ, Han da W, Dutta SK, Iyer S, Karumanchi SA, Kim KI, Couch FJ, Mukhopadhyay D. Sinha S, et al. J Cell Sci. 2011 Jul 1;124(Pt 13):2132-42. doi: 10.1242/jcs.087122. Epub 2011 Jun 7. J Cell Sci. 2011. PMID: 21652636 Free PMC article. - Hypoxic stabilization of mRNA is HIF-independent but requires mtROS.
Fortenbery GW, Sarathy B, Carraway KR, Mansfield KD. Fortenbery GW, et al. Cell Mol Biol Lett. 2018 Oct 4;23:48. doi: 10.1186/s11658-018-0112-2. eCollection 2018. Cell Mol Biol Lett. 2018. PMID: 30305827 Free PMC article. - Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.
Etienne-Grimaldi MC, Formento P, Degeorges A, Pierga JY, Delva R, Pivot X, Dalenc F, Espié M, Veyret C, Formento JL, Francoual M, Piutti M, de Crémoux P, Milano G. Etienne-Grimaldi MC, et al. Br J Clin Pharmacol. 2011 Jun;71(6):921-8. doi: 10.1111/j.1365-2125.2010.03896.x. Br J Clin Pharmacol. 2011. PMID: 21204912 Free PMC article. - The molecular basis of von Hippel-Lindau disease.
Iliopoulos O, Kaelin WG Jr. Iliopoulos O, et al. Mol Med. 1997 May;3(5):289-93. Mol Med. 1997. PMID: 9205944 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous